Dr. Robles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Taylor Blvd
Ste 202
Concord, CA 94523Phone+1 925-677-5041Fax+1 925-677-5027
Summary
- Website: www.dvohmg.com
Office Hours: 9-5
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1989 - 1993
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1986 - 1989
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1986
Certifications & Licensure
CA State Medical License 1988 - 2026
PA State Medical License 1987 - 1996- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014
- Top MD Consumers Checkbook
Clinical Trials
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- 57 citationsEffect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed kaposi's sarcoma in patients with AIDSRobert Robles, Denise Lugo, Lauren Gee, Mark A. Jacobson
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999-01-01 - 47 citationsA phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other...Sunil Sharma, V. V. Abhyankar, R. E. Burgess, Jeffrey R. Infante, R. C. Trowbridge
Annals of Oncology. 2010-02-01 - 126 citationsRandomized Phase II study of R-CHOP with or without bortezomib in previously untreated patients with non-germinal center B-cell-like diffuse large B-cell lymphomaJohn P. Leonard, Kathryn S. Kolibaba, James A. Reeves, Anil Tulpule, Ian W. Flinn
Journal of Clinical Oncology. 2017-09-01
External Links
- Websitehttp://www.dvohmg.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
